Biopharmaceuticals Market | Analysis | Overview (2018-2023)
Biopharmaceuticals Market – Segmented By Products (Monoclonal Antibodies, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Synthetic Immunomodulators, Vaccines), By Application, By Geography- Growth, Trends, and Forecast (2018 - 2023)

PUBLISHED

JUL 2018

Biopharmaceuticals Market – Segmented By Products (Monoclonal Antibodies, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Synthetic Immunomodulators, Vaccines), By Application, By Geography- Growth, Trends, and Forecast (2018 - 2023)

Purchase Report

Biopharmaceuticals Market Overview

The Biopharmaceuticals market was valued at USD 218,483.1 million in 2017, is expected to register a CAGR of about 8.59% during the forecast period, 2018-2023. Biopharmaceutical products include (but are not limited to) monoclonal antibodies, recombinant growth factors, purified proteins, recombinant proteins, recombinant hormones, synthetic immunomodulators, vaccines, and recombinant enzyme. Increasing acceptance for biopharmaceuticals, the ability of biopharmaceuticals to treat previously untreatable diseases, huge market demand are the major factors which are leading to the growth of the market. However, increasing demand for affordable biopharmaceuticals, high-end manufacturing requirements, complicated and cumbersome regulatory requirements are hindering the market growth.

Increasing Acceptance for Biopharmaceuticals and Significant Market Demand Propels the Growth of Biopharmaceuticals Market

Opportunities in biopharmaceuticals have been increasing over the past decade. The efficacy and the safety of the drugs are some of the key product features that drive the market’s growth. There have been biopharmaceutical products that are improving the quality of life and reducing the death rates in patients with HIV/AIDs, cancer, cystic fibrosis, rheumatoid arthritis. Biopharmaceuticals have reduced the number of deaths caused due to cancer and HIV/AIDS in the last decade. The efficacy of the drugs and their safety has increased the acceptance of biopharmaceuticals.

High-end Manufacturing Requirements Hinder the Growth of Biopharmaceuticals Market

Unlike conventional pharmaceuticals, biopharmaceuticals are manufactured using living biological systems. Due to this, biopharmaceutical manufacturing requires specialized equipment and devices such as incubators that can support these biological systems. The cost of these devices and equipment is high as compared to regular manufacturing equipment. Along with this, most biopharmaceuticals require custom built manufacturing equipment and highly specialized personnel to operate them. Due to these high-end manufacturing requirements, the resources and time required to setup a biopharmaceutical manufacturing facility are very high, which makes scaling really tough. So, these factors are acting as a restraint for the biopharmaceuticals market.

Market Segmentation Insights for the Biopharmaceuticals Market

The global Biopharmaceuticals market has been segmented based on product, application, and geography.

The products segment includes monoclonal antibodies, recombinant growth factors, purified proteins, recombinant proteins, recombinant hormones, synthetic immunomodulators, and vaccines. The Monoclonal Antibodies are further segmented into Anti Cancer Monoclonal Antibodies, Anti-inflammatory Monoclonal Antibodies, and Other Monoclonal Antibodies. The Recombinant Growth Factors include  Erythropoietin and Granulocyte Colony Stimulating Factor. The Purified Proteins include Leukemia Inhibitory Factor (LIF), P53 Protein, P38 Protein, Others. The Recombinant Proteins include Serum Albumin, Amyloid Protein, Defensin, Transferrin. The Recombinant Hormones include Recombinant Human Growth Hormone (HGH), Recombinant Insulin, Others. The Vaccines include Recombinant Vaccines (Cancer Vaccines, Malaria Vaccines, Ebola Vaccine, Hepatitis-b Vaccine, Tetanus Vaccine, Diptheria Vaccine, Cholera Vaccine, Others), Conventional Vaccines (Polio Vaccine, Pox Vaccine, Others), Recombinant Enzymes (Enterokinase, Cyclase, Caspase, Cathepsin), Cell And Gene Therapies (Allogeneic Products, Autologous Products), Acellular Products, Others (Blood Factors, Others).

The applications include oncology, inflammatory and infectious diseases, autoimmune disorders, metabolic disorders, hormonal disorders, disease prevention, cardiovascular diseases, and neurological diseases.

North America to Dominate the Biopharmaceuticals Market

The biopharmaceuticals market is segmented by type of treatment and geography. By geography, it is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa and South America.

North America dominates the biopharmaceuticals market due to rapid technological advancements and high investment & funding to support the development of biopharmaceuticals. Asia-Pacific is also expected to propel the biopharmaceuticals market owing to factors, such as increasing accessibility to healthcare facilities in the region and increasing economic growth.

Key Developments in the Biopharmaceuticals Market

  • January 2018: GE Healthcare’s Flex Factory single-use bio manufacturing platform has been selected by Clover Biopharmaceuticals, a Chinese developer of biologics, for its new facility located in Changxing, Zhejiang.
  • January 2018: Sandoz, a Novartis division and the global leader in biosimilars, announced a global partnership with Asia's premier biopharmaceuticals company, Biocon, to develop, manufacture and commercialize multiple biosimilars in immunology and oncology for patients worldwide.

The major companies include AbbVie, Amgen, Bristol – Myers Squibb, Eli Lily & Co., Johnson & Johnson, Merck & Co. Inc, GlaxoSmithKline PLC, Roche, Pfizer and Novartis AG, among others.

Biopharmaceuticals Market Segmentation

Biopharmaceuticals Market by Products

      • Monoclonal Antibodies
        • Anti Cancer Monoclonal Antibodies
        • Anti-inflammatory Monoclonal Antibodies
        • Other Monoclonal Antibodies
      • Recombinant Growth Factors
        • Erythropoietin
        • Granulocyte Colony Stimulating Factor
      • Purified Proteins
        • Leukemia Inhibitory Factor (LIF)
        • P53 Protein
        • P38 Protein
        • Others
      • Recombinant Proteins
        • Serum Albumin
        • Amyloid Protein
        • Defensin
        • Transferrin
      • Recombinant Hormones
        • Recombinant Human Growth Hormone (HGH)
        • Recombinant Insulin
        • Others
      • Synthetic Immunomodulators
      • Vaccines
        • Recombinant Vaccines
          • Cancer Vaccines
          • Malaria Vaccines
          • Ebola Vaccine
          • Hepatitis-b Vaccine
          • Tetanus Vaccine
          • Diptheria Vaccine
          • Cholera Vaccine
          • Others
        • Conventional Vaccines
          • Polio Vaccine
          • Pox Vaccine
          • Others
        • Recombinant Enzymes
          • Enterokinase
          • Cyclase
          • Caspase
          • Cathepsin
        • Cell And Gene Therapies
          • Allogeneic Products
          • Autologous Products
        • Acellular Products
        • Others
          • Blood Factors
          • Others

Biopharmaceuticals Market by Application

  • Oncology
  • Inflammatory And Infectious Diseases
  • Autoimmune Disorders
  • Metabolic Disorders
  • Hormonal Disorders
  • Disease Prevention
  • Cardiovascular Diseases
  • Neurological Diseases
  • Other Diseases

Biopharmaceuticals Market by Region

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific        
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Middle East and Africa  
    • GCC
    • South Africa
  • South America
    • Brazil
    • Argentina

Country-Level Data Points Coverage and Deliverables for Biopharmaceuticals Market

   

Biopharmaceuticals Market Report Summary

Metrics

Details

Industry

Biopharmaceuticals Market

Study Period

(2015 – 2023)

Growth Rate

8.59%

Segmentation Scope

By products (monoclonal antibodies, recombinant growth factors, purified proteins, recombinant proteins, recombinant hormones, synthetic immunomodulators, vaccines),

 

By application (oncology, inflammatory and infectious diseases, autoimmune disorders, metabolic disorders, hormonal disorders, disease prevention, cardiovascular diseases, neurological diseases)

Regional Scope

North America (US, Canada, Mexico), Europe (UK, Germany, France, Italy Spain, Rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea and Rest of Asia Pacific), Middle East & Africa (GCC, South Africa and Rest of MEA) and South America (Brazil, Argentina and Rest of South America)

Key Developments

January 2018: GE Healthcare’s Flex Factory single-use bio manufacturing platform has been selected by Clover Biopharmaceuticals, a Chinese developer of biologics, for its new facility located in Changxing, Zhejiang.

 

January 2018: Sandoz, a Novartis division and the global leader in biosimilars, announced a global partnership with Asia's premier biopharmaceuticals company, Biocon, to develop, manufacture and commercialize multiple biosimilars in immunology and oncology for patients worldwide.

Companies Covered

AbbVie, Amgen, Bristol – Myers Squibb, Eli Lily & Co., Johnson & Johnson, Merck & Co. Inc, GlaxoSmithKline PLC, Roche, Pfizer and Novartis AG, among others

Report Offerings

Biopharmaceuticals Market offers latest trends, growth prospects, industry competitiveness, major players, regional share of market and forecast to 2023.

Reasons to Purchase the Biopharmaceuticals Market Report

  • Current and future of Biopharmaceuticals market outlook in the developed and emerging markets
  • Analysis of various perspectives of the market with the help of Porter’s five forces analysis
  • The segment that is expected to dominate the market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, market shares, and strategies employed by the major market players
  • 3-month analyst support, along with the market estimate sheet (in Excel)

Customization of the Biopharmaceuticals Market Report

This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs

1. Introduction

                1.1 Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

                5.1 Current Market Scenario

                5.2 Porter's Five Forces Analysis

                                5.2.1 Bargaining Power of Suppliers

                                5.2.2 Bargaining Power of Consumers

                                5.2.3 Threat of New Entrants

                                5.2.4 Threat of Substitute Product and Services

                                5.2.5 Degree of Competition

6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)

                6.1 Market Drivers

                                6.1.1 Increasing Acceptance for Biopharmaceuticals

                                6.1.2 Ability of Biopharmaceuticals to Treat Previously Untreatable Diseases

                                6.1.3 Huge Market Demand

                6.2 Market Restraints

                                6.2.1 Increasing Demand for Affordable Biopharmaceuticals

                                6.2.2 High-end Manufacturing Requirements

                                6.2.3 Complicated and Cumbersome Regulatory Requirements

                6.3 Opportunities

                6.4 Key Challenges

7. Market Segmentation

                7.1 By Product Type

                                7.1.1 Monoclonal Antibodies

                                                7.1.1.1 Anti Cancer Monoclonal Antibodies

                                                7.1.1.2 Anti-inflammatory Monoclonal Antibodies

                                                7.1.1.3 Other Monoclonal Antibodies

                                7.1.2 Recombinant Growth Factors

                                                7.1.2.1 Erythropoietin

                                                7.1.2.2 Granulocyte Colony Stimulating Factor

                                7.1.3 Purified Proteins

                                                7.1.3.1 Leukemia Inhibitory Factor (LIF)

                                                7.1.3.2 P53 Protein

                                                7.1.3.3 P38 Protein

                                                7.1.3.4 Others

                                7.1.4 Recombinant Proteins

                                                7.1.4.1 Serum Albumin

                                                7.1.4.2 Amyloid Protein

                                                7.1.4.3 Defensin

                                                7.1.4.4 Transferrin

                                7.1.5 Recombinant Hormones

                                                7.1.5.1 Recombinant Human Growth Hormone (HGH)

                                                7.1.5.2 Recombinant Insulin

                                                7.1.5.3 Others

                                7.1.6 Synthetic Immunomodulators

                                7.1.7 Vaccines

                                                7.1.7.1 Recombinant Vaccines

                                                                7.1.7.1.1 Cancer Vaccines

                                                                7.1.7.1.2 Malaria Vaccines

                                                                7.1.7.1.3 Ebola Vaccine

                                                                7.1.7.1.4 Hepatitis-b Vaccine

                                                                7.1.7.1.5 Tetanus Vaccine

                                                                7.1.7.1.6 Diptheria Vaccine

                                                                7.1.7.1.7 Cholera Vaccine

                                                                7.1.7.1.8 Others

                                                7.1.7.2 Conventional Vaccines

                                                                7.1.7.2.1 Polio Vaccine

                                                                7.1.7.2.2 Pox Vaccine

                                                                7.1.7.2.3 Others

                                                7.1.7.3 Recombinant Enzymes

                                                                7.1.7.3.1 Enterokinase

                                                                7.1.7.3.2 Cyclase

                                                                7.1.7.3.3 Caspase

                                                                7.1.7.3.4 Cathepsin

                                                7.1.7.4 Cell And Gene Therapies

                                                                7.1.7.4.1 Allogeneic Products

                                                                7.1.7.4.2 Autologous Products

                                                7.1.7.5 Acellular Products

                                                7.1.7.6 Others

                                                                7.1.7.6.1 Blood Factors

                                                                7.1.7.6.2 Others

                7.2 By Therapeutic Application

                                7.2.1 Oncology

                                7.2.2 Inflammatory And Infectious Diseases

                                7.2.3 Autoimmune Disorders

                                7.2.4 Metabolic Disorders

                                7.2.5 Hormonal Disorders

                                7.2.6 Disease Prevention

                                7.2.7 Cardiovascular Diseases

                                7.2.8 Neurological Diseases

                                7.2.9 Other Diseases

                7.3 By Geography

                                7.3.1 North America

                                                7.3.1.1 United States

                                                7.3.1.2 Canada

                                                7.3.1.3 Mexico

                                7.3.2 Europe

                                                7.3.2.1 United Kingdom

                                                7.3.2.2 Germany

                                                7.3.2.3  France

                                                7.3.2.4 Italy

                                                7.3.2.5 Spain

                                                7.3.2.6 Rest of Europe

                                7.3.3 Asia-Pacific

                                                7.3.3.1 India

                                                7.3.3.2 China

                                                7.3.3.3 Japan

                                                7.3.3.4 Australia

                                                7.3.3.5 South Korea

                                                7.3.3.6 Rest of Asia-Pacific

                                7.3.4 South America

                                                7.3.4.1 Brazil

                                                7.3.4.2 Argentina

                                                7.3.4.3 Rest Of South America

                                7.3.5 Middle East and Africa

                                                7.3.5.1 GCC

                                                7.3.5.2 South Africa

                                                7.3.5.3 Rest Of Middle-East & Africa

8. Competitive Landscape

                8.1 Mergers & Acquisition Analysis

                8.2 Agreements, Collaborations, and Partnerships

                8.3 New Products Launches

9. Key Players

                9.1 Abbvie Inc.

                9.2 Amgen Inc.

                9.3 Bristol-Myers Squibb Company

                9.4 Eli Lily & Co.

                9.5 Johnson & Johnson

                9.6 Novartis AG

                9.7 Novo Nordisk Inc.

                9.8 Pfizer Inc.

                9.9 GlaxoSmithKline Plc.

                9.10 Roche Holding AG

                9.11 Others

10. Future Outlook

Purchase Report

Our Clients Include View All

Looking to Customize Report?